Jefferson Update in Neurosurgery 2022
IMPORTANT BROWSER INFORMATION
This site will not work on Internet Explorer 8. Please use:
Advancements in the field of neurosurgery are occurring at an increasingly rapid rate. The integration of these advances into clinical practice often lags behind the rate at which they emerge in the literature. Therefore, a critical appraisal of the most recent and most influential advances in the various fields of neurosurgery is necessary to effectively incorporate these advances into clinical practice. Thomas Jefferson University is a world leader in neurosurgical research and practice. Current faculty and alumni from its residency and fellowship training programs are often on the cutting edge of neurosurgery.
In this virtual interdisciplinary CE activity, we will highlight the latest advances in the field of neurosurgery and identify ways in which practitioners from all fields can improve their practice and optimize the care for their patients by effectively integrating these changes into practice. In addition to the major topics of neurovascular disease, neuro-oncology, spinal cord injury, neurotrauma, neuroimaging, and functional neurosurgery, we will also discuss how to evaluate one’s practice, improve patient safety, and limit medical errors using quality improvement tools. All practitioners who take care of patients with neurological illness could benefit from this event, including neurosurgeons, neurologists, neuro-intensivists, neuroradiologist, anesthesiologist, and practitioners who might refer patients for neurolosurgical care.
To successfully complete this activity, the required evaluation must be completed no later than Sunday, July 31, 2022. Thereafter, the evaluation will no longer be available and credits will not be issued. No refunds will be offered for failure to complete the required evaluation by the stated deadline.
This course is designed for physicians, physician assistants, nurse practitioners, and nurses.
Following this educational activity, learners will be able to:
- Evaluate the application of novel cerebrovascular treatment options for the management of common neurovascular conditions, including streamlined, multidisciplinary management of ischemic cerebrovascular disease, intracranial aneurysms, and arteriovenous malformations.
- Simplify nuances involved in developing a complex neurovascular practice in underserved areas.
- Appraise novel therapies for neoplastic processes of the central nervous system, including endoscopic, minimally invasive, and complex cranial approaches.
- Employ up-to-date treatment strategies for the management of spinal cord injury and degenerative disease of the spine using and evidence-based approach.
- Interpret the risks and benefits of various neuromodulatory, ablative, and treatment strategies for neurodegenerative conditions, chronic pain, and seizure disorders.
- Analyze patient care gaps and methods for improving patient safety, medical errors, and multidisciplinary communication to improve the quality of neurosurgical care in practice.
- Utilize new technologies and networking platforms for the development of a neurosurgical practice.
- Explain the role of brain-computer-interface and novel applications biomedical science in the treatment and rehabilitation of patients with neurological disease.
Any commercial or in-kind support received for this educational activity will be published and announced prior to the start of the activity.
This draft agenda is subject to change, which may affect the credit count.
Thomas Jefferson University endorses the ACME Standards for Integrity and Independence in Accredited Continuing Education and the policies that supplement the Standards.
All planners, faculty, and others in control of educational content are required to disclose any relevant financial relationships with ACCME defined ineligible companies within the past 24 months. Any conflicts of interests have been mitigated prior to this educational activity.
Such disclosures will be available prior to the start of the activity. Jefferson conflict of interest mitigation process may result in changes to the program agenda.
The following planning committee members have no financial relationships to disclose.
Chengyuan Wu, MD-Activity Director
Richard F. Schmidt, MD-Activity Director
Christopher J. Farrell, MD
Giuliana Labella, MSN
Caitlin Harley, MSN
Heather Brock, MSN
The following planning committee members have financial relationships to disclose.
M. Reid Gooch, MD-Activity Director
Kevin Hines, MD
Yusef Imani, MD
Gentian Toshkezi, MD
Hermes Garcia, MD
Michael Lemole, MD
Kalyan Sajja, MD
Aditya Pandey, MD
Ashwini Sharan, MD
The following faculty have no financial relationships to disclose.
Chengyuan Wu, MD-Activity Director
Richard F. Schmidt, MD-Activity Director
Christopher Farrell, MD
Nabeel Herial, MD, MPH
Christian Hoelscher, MD
Omaditya Khanna, MD
Caio Matias, MD
Hekmat Zarzour, MD
The following faculty have financial relationships to disclose.
M. Reid Gooch, MD-Activity Director
James Evans, MD
Product Development/Royalties/Patent Beneficiary: Mizuho
Joshua Heller, MD, MBA
Consultant: ATEC, Nuvasive, Providence Medical Technology, SI Bone, Stryker, Surgalign, Zimmer Biomet; Researcher: Ethicon;
Royalties/Patent Beneficiary: Spine Biopharma
Pascal Jabbour, MD
Consultant: Cerus, Medtronic, Microvention
Majail Serruya, MD
Co-Founder: Nuromo (no FDA approved products)
All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the U.S. FDA for the treatment of disease(s).
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.
It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.
In support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians: This educational activity is designated for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: This activity awards 6.25 nursing contact hours.
Other Healthcare Professionals: This educational activity is designated for 6.25 AMA PRA Category 1 Credits™. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Credit count includes .25 credit (15 minutes) for completion of the required evaluation.
- 6.25 AMA PRA Category 1 Credit™
- 6.25 Attendance
- 6.25 CNE
|Nurse/Other Health Professionals||$60|
|Jefferson Health Physicians, Nurse and Other Health Professionals||$60|
|All Residents and Fellows||$0|
To register online, you must have a CPD @ JeffLearn account.
- Login or create an account. - Note: This website will not work on Internet Explorer 8.
Final price will be reflected on check out. You must be logged in to see the "Add to Cart" function.
- Check out and pay with American Express, Visa or Mastercard.
No refunds will be given after Thursday, June 2, 2022. See full refund policy.
Requests for refunds must be submitted in writing and received by OCPD before Thursday, June 2, 2022. Registrants who fail to attend the conference are responsible for the entire registration fee. All refunds will be processed after the conference concludes.
Should any emergency arise, of any nature, prior to the opening conference date that would prevent its schedule opening (destruction or damage to the facility by fire, flood, storms, acts of God, etc., or declaration of any emergency by the state of Pennsylvania or the United States Government), Jefferson reserves the right to cancel or postpone the conference. In the event of cancellation or postponement, Jefferson will refund registration fees, but is not responsible for related costs or expenses to registrants, including cancellation fees assessed by hotels, airlines or travel agencies.
RECORDING AND PHOTOGRAPHY STRICTLY PROHIBITED
Unauthorized recording or photography at a Jefferson-sponsored event is strictly prohibited. Individuals found violating this policy will be removed from the online activity or asked to leave from the live activity. No credits or refund will be issued.
JEFFERSON RELEASE POLICY
Jefferson may record/livestream/photograph this activity. These images/recordings, along with your name, may be used in Jefferson publications or on the Jefferson website. If you verbally submit any questions for Q&A sessions, you are agreeing to be recorded and to have that recording available in enduring materials. Once photographed, filmed, recorded, or videotaped, you waive any right of inspection or approval to which such images/recordings may be put and Jefferson has the right to use, publish, reproduce, modify, adapt and distribute at any time in any manner or medium.
You understand that it is your right to withhold consent to this Jefferson policy or to withdraw your previous consent at any time. You further understand that, without your consent, it is not possible to process your course registration request.
JEFFERSON HIPAA POLICY
You understand that, as an attendee of this conference hosted by Thomas Jefferson University, Jefferson University Physicians and Thomas Jefferson University Hospitals, Inc. (collectively “Jefferson”), you may gain access to certain proprietary information (“Confidential Information”), including Protected Health Information (“PHI”).
You agree to maintain the confidentiality of all Confidential Information, including PHI, obtained from any source. You agree that you will take all necessary steps to protect such Confidential Information and shall not directly or indirectly disclose or use it in any manner or for any reason, other than as necessary to complete the activity.
In furtherance of the above, you agree not to take photographs, record in any manner or otherwise reproduce any such Confidential Information. You understand that any unauthorized use or disclosure of Confidential Information by the undersigned may result in possible legal action against you by Jefferson whose confidentiality is breached.